UROGENITAL CANCERS : SYMPTOMS, DIAGNOSIS AND TREATMENT OF Urogenital cancers are varied, since they include tumors of the kidney and bladder, and, in men, of the prostate and testicle. Urogenital cancers differ widely. Treatment strategies are adapted to each patient and determined via a multidisciplinary consultation meeting. Prostate cancer is the most frequent of these cancers, with almost

70,000

DECIPHERING CENTROMERES TO UNDERSTAND HOW CANCER CELLS Deciphering centromeres to understand how cancer cells develop. Centromeres are, in most of the cases in humans, the center of our chromosomes and play an essential role in the conservation of our genetic makeup during cell division. Changes to this process can cause cell transformation and, ultimately, can allow cancer to develop. WHAT ARE THE SIDE EFFECTS OF PROTON THERAPY? Headaches, nausea and vomiting: These are the result of swelling in or around the tumor, which reacts to the irradiation. This swelling may lead to irritation of the area of the brain that controls nausea and/or vomiting. Alopecia or hair loss: A result of the rays, this is temporary and appears only where the rays pass; hair grows back within COMPOSERS OF THE MUSE-IC PROJECT The music of Manhattan-based composer Alexandra du Bois (Ph.D. Stony Brook University; M.M. The Juilliard School; B.M. Indiana University Jacobs School of Music) has been performed in concert halls across five continents—her travels connecting her tangibly to the places that inform and inspire her work—music that “attempts to be a conscience in a time of oblivion” (Kronos Quartet’s MASS SPECTROMETRY AND PROTEOMICS FACILITY: INSTITUT CURIESEE MORE ON SCIENCE.INSTITUT-CURIE.ORG CHRISTOPHE LE TOURNEAU Christophe Le Tourneau, MD, PhD, is senior Medical Oncologist at the Institut Curie and Full Professor of Medicine at Paris-Saclay University. He is heading the Department of Drug Development and Innovation (D3i) as well as the Head and Neck Clinic. Christophe Le Tourneau was certified in Medical Oncology in 2005 and got his PhD in

Clinical

ENTREE-LUNG (GSK 205801) Participants will be stratified by histology (squamous vs. non-squamous) and line of anti-programmed cell death ligand 1 (PD 1) therapy (first vs. second line). Initially, the study will evaluate the GSK3359609 inducible T-cell co-stimulator (ICOS) agonist in combination with SoC docetaxel compared to docetaxel alone

(sub-study 1).

SYLVIE BONVALOT

Présentation. Sylvia Bonvalot has specialized in surgery of sarcoma and complex tumors for around twenty years. After working as Chief resident in digestive surgery, she worked at Gustave Roussy from 1994 to 2015, before joining Institut Curie. She has treated over 4,000 patients suffering from sarcoma or complex tumors of the abdomen and

soft

BREAST CANCER

This course focuses on breast cancers from both a biological and a clinical perspective. It will cover the biology of breast cancers in the context of pathology, diagnostics of the disease and treatments, ongoing medical trials as well as modalities of follow-up. A special focus will emphasize recent data on basal-like and hereditary breast cancers, their new therapeutic strategies and the UMR168 - PHYSICO-CHIMIE CURIE LAB - CENTRE DE RECHERCHE DE UMR168 – Physico-Chimie Curie Lab. Open internship positions are available on teams websites. The goal of the unit is to uncover the role of physical laws in the architecture and functions of cellular systems. To this end, the teams follow cross-disciplinary UROGENITAL CANCERS : SYMPTOMS, DIAGNOSIS AND TREATMENT OF Urogenital cancers are varied, since they include tumors of the kidney and bladder, and, in men, of the prostate and testicle. Urogenital cancers differ widely. Treatment strategies are adapted to each patient and determined via a multidisciplinary consultation meeting. Prostate cancer is the most frequent of these cancers, with almost

70,000

DECIPHERING CENTROMERES TO UNDERSTAND HOW CANCER CELLS Deciphering centromeres to understand how cancer cells develop. Centromeres are, in most of the cases in humans, the center of our chromosomes and play an essential role in the conservation of our genetic makeup during cell division. Changes to this process can cause cell transformation and, ultimately, can allow cancer to develop. WHAT ARE THE SIDE EFFECTS OF PROTON THERAPY? Headaches, nausea and vomiting: These are the result of swelling in or around the tumor, which reacts to the irradiation. This swelling may lead to irritation of the area of the brain that controls nausea and/or vomiting. Alopecia or hair loss: A result of the rays, this is temporary and appears only where the rays pass; hair grows back within COMPOSERS OF THE MUSE-IC PROJECT The music of Manhattan-based composer Alexandra du Bois (Ph.D. Stony Brook University; M.M. The Juilliard School; B.M. Indiana University Jacobs School of Music) has been performed in concert halls across five continents—her travels connecting her tangibly to the places that inform and inspire her work—music that “attempts to be a conscience in a time of oblivion” (Kronos Quartet’s MASS SPECTROMETRY AND PROTEOMICS FACILITY: INSTITUT CURIESEE MORE ON SCIENCE.INSTITUT-CURIE.ORG CHRISTOPHE LE TOURNEAU Christophe Le Tourneau, MD, PhD, is senior Medical Oncologist at the Institut Curie and Full Professor of Medicine at Paris-Saclay University. He is heading the Department of Drug Development and Innovation (D3i) as well as the Head and Neck Clinic. Christophe Le Tourneau was certified in Medical Oncology in 2005 and got his PhD in

Clinical

ENTREE-LUNG (GSK 205801) Participants will be stratified by histology (squamous vs. non-squamous) and line of anti-programmed cell death ligand 1 (PD 1) therapy (first vs. second line). Initially, the study will evaluate the GSK3359609 inducible T-cell co-stimulator (ICOS) agonist in combination with SoC docetaxel compared to docetaxel alone

(sub-study 1).

SYLVIE BONVALOT

Présentation. Sylvia Bonvalot has specialized in surgery of sarcoma and complex tumors for around twenty years. After working as Chief resident in digestive surgery, she worked at Gustave Roussy from 1994 to 2015, before joining Institut Curie. She has treated over 4,000 patients suffering from sarcoma or complex tumors of the abdomen and

soft

BREAST CANCER

This course focuses on breast cancers from both a biological and a clinical perspective. It will cover the biology of breast cancers in the context of pathology, diagnostics of the disease and treatments, ongoing medical trials as well as modalities of follow-up. A special focus will emphasize recent data on basal-like and hereditary breast cancers, their new therapeutic strategies and the UMR168 - PHYSICO-CHIMIE CURIE LAB - CENTRE DE RECHERCHE DE UMR168 – Physico-Chimie Curie Lab. Open internship positions are available on teams websites. The goal of the unit is to uncover the role of physical laws in the architecture and functions of cellular systems. To this end, the teams follow cross-disciplinary UROGENITAL CANCERS : SYMPTOMS, DIAGNOSIS AND TREATMENT OF Urogenital cancers are varied, since they include tumors of the kidney and bladder, and, in men, of the prostate and testicle. Urogenital cancers differ widely. Treatment strategies are adapted to each patient and determined via a multidisciplinary consultation meeting. Prostate cancer is the most frequent of these cancers, with almost

70,000

WHAT ARE ENT CANCERS? : SYMPTOMS, DIAGNOSIS AND TREATMENT Cancer is a serious disease whose cure will depend on whether it is localised or, on the contrary, has metastasized with extended lesions. The five-year cure rate varies between 20% and 80%. There are many types of ENT cancers. They are generally classed according to the location of the tumour. Buccal cavity: tongue, jaw, floor of the mouth IMMUNOTHERAPY IN FRANCE Immunotherapy is a priority for Institut Curie, which houses the only Cancer Immunotherapy center in France today. A number of specialists are working out of this center, including physicians, researchers, nurses and research coordinators. There are 20

UMR3666/U1143

The Curie Institute is a cancer research and care centre characterized by interdisciplinarity. The Cellular and Chemical Biology department cherishes this spirit by uniting within the same perimeter researchers from various backgrounds, notably organic chemistry and cell biology. It is our objective to address the timeliest challenges in life sciences and biomedicine from unique angles SPATIO-TEMPORAL DYNAMICS OF IMMUNE CELLS We work at the interface of cell biology, immunology and biophysics. We aim at deciphering the fundamental cell biological mechanisms that control the spatio-temporal regulation of antigen presentation. In this context, we develop two main axis of research: the coordination between cell migration and antigen uptake and presentation in dendritic cells the role of cell

NICOLAS GIRARD

Nicolas Girard is a pneumologist specializing in thoracic oncology, for the treatment of patients with lung cancer or rare thoracic cancers. He is experienced in the treatment of thymic tumors—thymomas and thymic carcinomas—as part of his work in the

RYTHMIC network.

BIOCHEMISTRY AND BIOLOGY OF ANTICANCER DRUGS Biochemistry and biology of anticancer drugs. The objectives of our group are: To identify radiosensitizing molecules and / or new combinations of radiosensitizing molecules for the treatment of cancers where radiotherapy takes a major place despite sometimes modest results. Glioblastoma is BIOMIMETISM OF CELLULAR MOVEMENT Biomimetism of Cellular Movement. We study how cells change shape and move, with implications for understanding cancer invasion and metastasis. Our approach is based on the study of in vitro biomimetic systems and in vivo cellular and animal models to dissect the physical and biochemical mechanisms governing cell shape change and movement. CYTOSKELETAL ARCHITECTURE AND CELL MORPHOGENESIS Our team explores how the cytoskeleton is organized, how it controls the establishment of functional membrane domains devoted to polarized cell growth or cell division, and how it is remodeled at mitotic entry for the assembly of the mitotic spindle and contractile ring, two complex molecular machines promoting chromosome segregation and

cytokinesis.

CONSEILS NUTRITIONNELS ADAPTÉS AUX EFFETS SECONDAIRES … Evitez le thé et le café forts et tout ce qui peut favoriser la production de gaz pour échapper aux crampes abdominales (type boissons gazeuses, chewing-gums, bière, légumes type choux, légumes

secs).

FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. MASS SPECTROMETRY AND PROTEOMICS FACILITY: INSTITUT CURIESEE MORE ON SCIENCE.INSTITUT-CURIE.ORG WHAT ARE THE SIDE EFFECTS OF PROTON THERAPY? Headaches, nausea and vomiting: These are the result of swelling in or around the tumor, which reacts to the irradiation. This swelling may lead to irritation of the area of the brain that controls nausea and/or vomiting. Alopecia or hair loss: A result of the rays, this is temporary and appears only where the rays pass; hair grows back within COMPOSERS OF THE MUSE-IC PROJECT The music of Manhattan-based composer Alexandra du Bois (Ph.D. Stony Brook University; M.M. The Juilliard School; B.M. Indiana University Jacobs School of Music) has been performed in concert halls across five continents—her travels connecting her tangibly to the places that inform and inspire her work—music that “attempts to be a conscience in a time of oblivion” (Kronos Quartet’s

GO30103 (TIGIT)

GO30103 (TIGIT) Phases précoces tumeurs solides. Ouvert depuis le: 03.20.2021. Site: Paris. Public cible. Adulte. A Phase Ia/Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors. ENTREE-LUNG (GSK 205801) Participants will be stratified by histology (squamous vs. non-squamous) and line of anti-programmed cell death ligand 1 (PD 1) therapy (first vs. second line). Initially, the study will evaluate the GSK3359609 inducible T-cell co-stimulator (ICOS) agonist in combination with SoC docetaxel compared to docetaxel alone

(sub-study 1).

ISABELLE AERTS

Contacter ISABELLE AERTS. Contact me by phone or by filling in the form below. Secretary : 0033144324601. Nom. Prénom. Adresse e-mail.

SYLVIE GLAISNER

Dr. Sylvie Glaisner is a medical specialist in hematology. She is head of the hematology Department of the hospital complex of the Curie Institute located on the sites of Paris and Saint-Cloud. She coordinates the multidisciplinary consultation meeting of Hematology and the implementation of the Hematology Service project integrating

the

SYLVIE BONVALOT

Présentation. Sylvia Bonvalot has specialized in surgery of sarcoma and complex tumors for around twenty years. After working as Chief resident in digestive surgery, she worked at Gustave Roussy from 1994 to 2015, before joining Institut Curie. She has treated over 4,000 patients suffering from sarcoma or complex tumors of the abdomen and

soft

CONSEILS NUTRITIONNELS ADAPTÉS AUX EFFETS SECONDAIRES … Evitez le thé et le café forts et tout ce qui peut favoriser la production de gaz pour échapper aux crampes abdominales (type boissons gazeuses, chewing-gums, bière, légumes type choux, légumes

secs).

FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. MASS SPECTROMETRY AND PROTEOMICS FACILITY: INSTITUT CURIESEE MORE ON SCIENCE.INSTITUT-CURIE.ORG WHAT ARE THE SIDE EFFECTS OF PROTON THERAPY? Headaches, nausea and vomiting: These are the result of swelling in or around the tumor, which reacts to the irradiation. This swelling may lead to irritation of the area of the brain that controls nausea and/or vomiting. Alopecia or hair loss: A result of the rays, this is temporary and appears only where the rays pass; hair grows back within COMPOSERS OF THE MUSE-IC PROJECT The music of Manhattan-based composer Alexandra du Bois (Ph.D. Stony Brook University; M.M. The Juilliard School; B.M. Indiana University Jacobs School of Music) has been performed in concert halls across five continents—her travels connecting her tangibly to the places that inform and inspire her work—music that “attempts to be a conscience in a time of oblivion” (Kronos Quartet’s

GO30103 (TIGIT)

GO30103 (TIGIT) Phases précoces tumeurs solides. Ouvert depuis le: 03.20.2021. Site: Paris. Public cible. Adulte. A Phase Ia/Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors. ENTREE-LUNG (GSK 205801) Participants will be stratified by histology (squamous vs. non-squamous) and line of anti-programmed cell death ligand 1 (PD 1) therapy (first vs. second line). Initially, the study will evaluate the GSK3359609 inducible T-cell co-stimulator (ICOS) agonist in combination with SoC docetaxel compared to docetaxel alone

(sub-study 1).

ISABELLE AERTS

Contacter ISABELLE AERTS. Contact me by phone or by filling in the form below. Secretary : 0033144324601. Nom. Prénom. Adresse e-mail.

SYLVIE GLAISNER

Dr. Sylvie Glaisner is a medical specialist in hematology. She is head of the hematology Department of the hospital complex of the Curie Institute located on the sites of Paris and Saint-Cloud. She coordinates the multidisciplinary consultation meeting of Hematology and the implementation of the Hematology Service project integrating

the

SYLVIE BONVALOT

Présentation. Sylvia Bonvalot has specialized in surgery of sarcoma and complex tumors for around twenty years. After working as Chief resident in digestive surgery, she worked at Gustave Roussy from 1994 to 2015, before joining Institut Curie. She has treated over 4,000 patients suffering from sarcoma or complex tumors of the abdomen and

soft

CONSEILS NUTRITIONNELS ADAPTÉS AUX EFFETS SECONDAIRES … Evitez le thé et le café forts et tout ce qui peut favoriser la production de gaz pour échapper aux crampes abdominales (type boissons gazeuses, chewing-gums, bière, légumes type choux, légumes

secs).

FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. UROGENITAL CANCERS : SYMPTOMS, DIAGNOSIS AND TREATMENT OF Urogenital cancers are varied, since they include tumors of the kidney and bladder, and, in men, of the prostate and testicle. Urogenital cancers differ widely. Treatment strategies are adapted to each patient and determined via a multidisciplinary consultation meeting. Prostate cancer is the most frequent of these cancers, with almost

70,000

DECIPHERING CENTROMERES TO UNDERSTAND HOW CANCER CELLS Deciphering centromeres to understand how cancer cells develop. Centromeres are, in most of the cases in humans, the center of our chromosomes and play an essential role in the conservation of our genetic makeup during cell division. Changes to this process can cause cell transformation and, ultimately, can allow cancer to develop. WHAT IS PROTON THERAPY? : EXTERNAL RADIOTHERAPY USING What is protontherapy? It is an external radiotherapy which uses the energy of a proton beam to destroy tumor cells. Due to the physical properties of this beam, the radiation dose delivered to the tumor can be increased, while the dose delivered to the healthy tissues close to the tumor is minimized. PROTON THERAPY CENTER The Proton Therapy Center is located in Orsay. It is one of the three technical platforms in the Radiotherapy department at Institut Curie. The first treatments administered were for melanoma of the eye, but since then tumor locations treated have become more diverse, with treatment of certain tumors at the base of the skull in particular, in adults and children.

INSTITUT CURIE

Description chiffres clés. Institut Curie’s Technology Transfer Office has served Institut Curie's researchers and clinicians since 2003 with full-spectrum intellectual property services. The office is responsible for the protection and the commercialization of Institut Curie discoveries and handles its R&D partnerships with Biotechs &

Industry.

MULTIMODAL IMAGING CENTER (US43-UMS2016) The Multimodal Imaging Center (MIC) was created on 1 January 2020 by the four trustees, the CNRS, the Inserm, the Institut Curie, and Université Paris-Saclay, as a service unit UMS2016/ US43. The MIC Unit brings together the expertise of Imaging (Light Microscopy, Electron cryo-Microscopy, Ionic Microscopy, Image Processing and Analysis) and makes available to the

MOLECULAR ONCOLOGY

Our goal is to identify genetic and epigenetic events involved in tumor progression and new therapeutic targets. We focus on two carcinomas, bladder and breast cancer, and on retinoblastoma, a pediatric cancer of the retina. We use bioinformatics, based on large-scale transcriptomic, genomic and sequencing data, to identify genes and pathways potentially involved in tumor

NICOLAS GIRARD

Nicolas Girard is a pneumologist specializing in thoracic oncology, for the treatment of patients with lung cancer or rare thoracic cancers. He is experienced in the treatment of thymic tumors—thymomas and thymic carcinomas—as part of his work in the

RYTHMIC network.

UMR168 - PHYSICO-CHIMIE CURIE LAB - CENTRE DE RECHERCHE DE UMR168 – Physico-Chimie Curie Lab. Open internship positions are available on teams websites. The goal of the unit is to uncover the role of physical laws in the architecture and functions of cellular systems. To this end, the teams follow cross-disciplinary FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. MASS SPECTROMETRY AND PROTEOMICS FACILITY: INSTITUT CURIESEE MORE ON SCIENCE.INSTITUT-CURIE.ORG WHAT ARE THE SIDE EFFECTS OF PROTON THERAPY? Headaches, nausea and vomiting: These are the result of swelling in or around the tumor, which reacts to the irradiation. This swelling may lead to irritation of the area of the brain that controls nausea and/or vomiting. Alopecia or hair loss: A result of the rays, this is temporary and appears only where the rays pass; hair grows back within COMPOSERS OF THE MUSE-IC PROJECT The music of Manhattan-based composer Alexandra du Bois (Ph.D. Stony Brook University; M.M. The Juilliard School; B.M. Indiana University Jacobs School of Music) has been performed in concert halls across five continents—her travels connecting her tangibly to the places that inform and inspire her work—music that “attempts to be a conscience in a time of oblivion” (Kronos Quartet’s

GO30103 (TIGIT)

GO30103 (TIGIT) Phases précoces tumeurs solides. Ouvert depuis le: 03.20.2021. Site: Paris. Public cible. Adulte. A Phase Ia/Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors. ENTREE-LUNG (GSK 205801) Participants will be stratified by histology (squamous vs. non-squamous) and line of anti-programmed cell death ligand 1 (PD 1) therapy (first vs. second line). Initially, the study will evaluate the GSK3359609 inducible T-cell co-stimulator (ICOS) agonist in combination with SoC docetaxel compared to docetaxel alone

(sub-study 1).

ISABELLE AERTS

Contacter ISABELLE AERTS. Contact me by phone or by filling in the form below. Secretary : 0033144324601. Nom. Prénom. Adresse e-mail.

SYLVIE GLAISNER

Dr. Sylvie Glaisner is a medical specialist in hematology. She is head of the hematology Department of the hospital complex of the Curie Institute located on the sites of Paris and Saint-Cloud. She coordinates the multidisciplinary consultation meeting of Hematology and the implementation of the Hematology Service project integrating

the

SYLVIE BONVALOT

Présentation. Sylvia Bonvalot has specialized in surgery of sarcoma and complex tumors for around twenty years. After working as Chief resident in digestive surgery, she worked at Gustave Roussy from 1994 to 2015, before joining Institut Curie. She has treated over 4,000 patients suffering from sarcoma or complex tumors of the abdomen and

soft

CONSEILS NUTRITIONNELS ADAPTÉS AUX EFFETS SECONDAIRES … Evitez le thé et le café forts et tout ce qui peut favoriser la production de gaz pour échapper aux crampes abdominales (type boissons gazeuses, chewing-gums, bière, légumes type choux, légumes

secs).

FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. MASS SPECTROMETRY AND PROTEOMICS FACILITY: INSTITUT CURIESEE MORE ON SCIENCE.INSTITUT-CURIE.ORG WHAT ARE THE SIDE EFFECTS OF PROTON THERAPY? Headaches, nausea and vomiting: These are the result of swelling in or around the tumor, which reacts to the irradiation. This swelling may lead to irritation of the area of the brain that controls nausea and/or vomiting. Alopecia or hair loss: A result of the rays, this is temporary and appears only where the rays pass; hair grows back within COMPOSERS OF THE MUSE-IC PROJECT The music of Manhattan-based composer Alexandra du Bois (Ph.D. Stony Brook University; M.M. The Juilliard School; B.M. Indiana University Jacobs School of Music) has been performed in concert halls across five continents—her travels connecting her tangibly to the places that inform and inspire her work—music that “attempts to be a conscience in a time of oblivion” (Kronos Quartet’s

GO30103 (TIGIT)

GO30103 (TIGIT) Phases précoces tumeurs solides. Ouvert depuis le: 03.20.2021. Site: Paris. Public cible. Adulte. A Phase Ia/Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors. ENTREE-LUNG (GSK 205801) Participants will be stratified by histology (squamous vs. non-squamous) and line of anti-programmed cell death ligand 1 (PD 1) therapy (first vs. second line). Initially, the study will evaluate the GSK3359609 inducible T-cell co-stimulator (ICOS) agonist in combination with SoC docetaxel compared to docetaxel alone

(sub-study 1).

ISABELLE AERTS

Contacter ISABELLE AERTS. Contact me by phone or by filling in the form below. Secretary : 0033144324601. Nom. Prénom. Adresse e-mail.

SYLVIE GLAISNER

Dr. Sylvie Glaisner is a medical specialist in hematology. She is head of the hematology Department of the hospital complex of the Curie Institute located on the sites of Paris and Saint-Cloud. She coordinates the multidisciplinary consultation meeting of Hematology and the implementation of the Hematology Service project integrating

the

SYLVIE BONVALOT

Présentation. Sylvia Bonvalot has specialized in surgery of sarcoma and complex tumors for around twenty years. After working as Chief resident in digestive surgery, she worked at Gustave Roussy from 1994 to 2015, before joining Institut Curie. She has treated over 4,000 patients suffering from sarcoma or complex tumors of the abdomen and

soft

CONSEILS NUTRITIONNELS ADAPTÉS AUX EFFETS SECONDAIRES … Evitez le thé et le café forts et tout ce qui peut favoriser la production de gaz pour échapper aux crampes abdominales (type boissons gazeuses, chewing-gums, bière, légumes type choux, légumes

secs).

FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. UROGENITAL CANCERS : SYMPTOMS, DIAGNOSIS AND TREATMENT OF Urogenital cancers are varied, since they include tumors of the kidney and bladder, and, in men, of the prostate and testicle. Urogenital cancers differ widely. Treatment strategies are adapted to each patient and determined via a multidisciplinary consultation meeting. Prostate cancer is the most frequent of these cancers, with almost

70,000

DECIPHERING CENTROMERES TO UNDERSTAND HOW CANCER CELLS Deciphering centromeres to understand how cancer cells develop. Centromeres are, in most of the cases in humans, the center of our chromosomes and play an essential role in the conservation of our genetic makeup during cell division. Changes to this process can cause cell transformation and, ultimately, can allow cancer to develop. WHAT IS PROTON THERAPY? : EXTERNAL RADIOTHERAPY USING What is protontherapy? It is an external radiotherapy which uses the energy of a proton beam to destroy tumor cells. Due to the physical properties of this beam, the radiation dose delivered to the tumor can be increased, while the dose delivered to the healthy tissues close to the tumor is minimized. PROTON THERAPY CENTER The Proton Therapy Center is located in Orsay. It is one of the three technical platforms in the Radiotherapy department at Institut Curie. The first treatments administered were for melanoma of the eye, but since then tumor locations treated have become more diverse, with treatment of certain tumors at the base of the skull in particular, in adults and children.

INSTITUT CURIE

Description chiffres clés. Institut Curie’s Technology Transfer Office has served Institut Curie's researchers and clinicians since 2003 with full-spectrum intellectual property services. The office is responsible for the protection and the commercialization of Institut Curie discoveries and handles its R&D partnerships with Biotechs &

Industry.

MULTIMODAL IMAGING CENTER (US43-UMS2016) The Multimodal Imaging Center (MIC) was created on 1 January 2020 by the four trustees, the CNRS, the Inserm, the Institut Curie, and Université Paris-Saclay, as a service unit UMS2016/ US43. The MIC Unit brings together the expertise of Imaging (Light Microscopy, Electron cryo-Microscopy, Ionic Microscopy, Image Processing and Analysis) and makes available to the

MOLECULAR ONCOLOGY

Our goal is to identify genetic and epigenetic events involved in tumor progression and new therapeutic targets. We focus on two carcinomas, bladder and breast cancer, and on retinoblastoma, a pediatric cancer of the retina. We use bioinformatics, based on large-scale transcriptomic, genomic and sequencing data, to identify genes and pathways potentially involved in tumor

NICOLAS GIRARD

Nicolas Girard is a pneumologist specializing in thoracic oncology, for the treatment of patients with lung cancer or rare thoracic cancers. He is experienced in the treatment of thymic tumors—thymomas and thymic carcinomas—as part of his work in the

RYTHMIC network.

UMR168 - PHYSICO-CHIMIE CURIE LAB - CENTRE DE RECHERCHE DE UMR168 – Physico-Chimie Curie Lab. Open internship positions are available on teams websites. The goal of the unit is to uncover the role of physical laws in the architecture and functions of cellular systems. To this end, the teams follow cross-disciplinary FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. MASS SPECTROMETRY AND PROTEOMICS FACILITY: INSTITUT CURIESEE MORE ON SCIENCE.INSTITUT-CURIE.ORG COMPOSERS OF THE MUSE-IC PROJECT The music of Manhattan-based composer Alexandra du Bois (Ph.D. Stony Brook University; M.M. The Juilliard School; B.M. Indiana University Jacobs School of Music) has been performed in concert halls across five continents—her travels connecting her tangibly to the places that inform and inspire her work—music that “attempts to be a conscience in a time of oblivion” (Kronos Quartet’s WHAT ARE THE SIDE EFFECTS OF PROTON THERAPY? Like all treatments, proton therapy may produce unwanted side effects. These effects vary considerably from one patient to another. They depend on the dose (photons and protons) administered, the location of the treatment and the reactions of each patient. ENTREE-LUNG (GSK 205801) A Phase II, Randomized, Open-label Platform Trial Utilizing a Master Protocol to Study Novel Regimens Versus Standard of Care Treatment in

NSCLC Participants

SYLVIE GLAISNER

Dr. Sylvie Glaisner is a medical specialist in hematology. She is head of the hematology Department of the hospital complex of the Curie Institute located on the sites of Paris and Saint-Cloud.

SYLVIE BONVALOT

Sylvia Bonvalot has specialized in surgery of sarcoma and complex tumors for around twenty years. After working as Chief resident in digestive surgery, she worked at Gustave Roussy from 1994 to 2015, before joining Institut Curie.

ISABELLE AERTS

Contact me by phone or by filling in the form below. Cette question permet de tester si vous êtes un visiteur humain et d'empêcher les soumissions automatiques de spam. CONSEILS NUTRITIONNELS ADAPTÉS AUX EFFETS SECONDAIRES … Evitez le thé et le café forts et tout ce qui peut favoriser la production de gaz pour échapper aux crampes abdominales (type boissons gazeuses, chewing-gums, bière, légumes type choux, légumes

secs).

BREAST CANCER

This course focuses on breast cancers from both a biological and a clinical perspective. It will cover the biology of breast cancers in the context of pathology, diagnostics of the disease and treatments, ongoing medical trials as well as modalities of follow-up. A special focus will emphasize recent data on basal-like and hereditary breast cancers, their new therapeutic strategies and the FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. MASS SPECTROMETRY AND PROTEOMICS FACILITY: INSTITUT CURIESEE MORE ON SCIENCE.INSTITUT-CURIE.ORG COMPOSERS OF THE MUSE-IC PROJECT The music of Manhattan-based composer Alexandra du Bois (Ph.D. Stony Brook University; M.M. The Juilliard School; B.M. Indiana University Jacobs School of Music) has been performed in concert halls across five continents—her travels connecting her tangibly to the places that inform and inspire her work—music that “attempts to be a conscience in a time of oblivion” (Kronos Quartet’s WHAT ARE THE SIDE EFFECTS OF PROTON THERAPY? Like all treatments, proton therapy may produce unwanted side effects. These effects vary considerably from one patient to another. They depend on the dose (photons and protons) administered, the location of the treatment and the reactions of each patient. ENTREE-LUNG (GSK 205801) A Phase II, Randomized, Open-label Platform Trial Utilizing a Master Protocol to Study Novel Regimens Versus Standard of Care Treatment in

NSCLC Participants

SYLVIE GLAISNER

Dr. Sylvie Glaisner is a medical specialist in hematology. She is head of the hematology Department of the hospital complex of the Curie Institute located on the sites of Paris and Saint-Cloud.

SYLVIE BONVALOT

Sylvia Bonvalot has specialized in surgery of sarcoma and complex tumors for around twenty years. After working as Chief resident in digestive surgery, she worked at Gustave Roussy from 1994 to 2015, before joining Institut Curie.

ISABELLE AERTS

Contact me by phone or by filling in the form below. Cette question permet de tester si vous êtes un visiteur humain et d'empêcher les soumissions automatiques de spam. CONSEILS NUTRITIONNELS ADAPTÉS AUX EFFETS SECONDAIRES … Evitez le thé et le café forts et tout ce qui peut favoriser la production de gaz pour échapper aux crampes abdominales (type boissons gazeuses, chewing-gums, bière, légumes type choux, légumes

secs).

BREAST CANCER

This course focuses on breast cancers from both a biological and a clinical perspective. It will cover the biology of breast cancers in the context of pathology, diagnostics of the disease and treatments, ongoing medical trials as well as modalities of follow-up. A special focus will emphasize recent data on basal-like and hereditary breast cancers, their new therapeutic strategies and the FRENCH FOUNDATION FOR CANCER RESEARCH The French foundation for cancer research Institut Curie fight against cancer thanks to an hospital, with the best experts, an internationally-renowned research centre and a teaching programmes to train tomorrow's cancer experts. UROGENITAL CANCERS : SYMPTOMS, DIAGNOSIS AND TREATMENT OF Urogenital cancers (prostate, kidney, bladder and testicle) are treated by the medical teams at Institut Curie. In a multidisciplinary consultation meeting, a personalized care plan is offered to each patient, with access to innovative treatment as soon as possible. WHAT IS PROTON THERAPY? : EXTERNAL RADIOTHERAPY USING What is protontherapy? It is an external radiotherapy which uses the energy of a proton beam to destroy tumor cells. Due to the physical properties of this beam, the radiation dose delivered to the tumor can be increased, while the dose delivered to the healthy tissues close to the tumor is minimized. PROTON THERAPY CENTER The Proton Therapy Center is located in Orsay. It is one of the three technical platforms in the Radiotherapy department at Institut Curie. The first treatments administered were for melanoma of the eye, but since then tumor locations treated have become more diverse, with treatment of certain tumors at the base of the skull in particular, in adults and children. MULTIMODAL IMAGING CENTER (US43-UMS2016) The Multimodal Imaging Center (MIC) was created on 1 January 2020 by the four trustees, the CNRS, the Inserm, the Institut Curie, and Université Paris-Saclay, as a service unit UMS2016/ US43. The MIC Unit brings together the expertise of Imaging (Light Microscopy, Electron cryo-Microscopy, Ionic Microscopy, Image Processing and Analysis) and makes available to the

INSTITUT CURIE

L'Institut Curie lutte contre le cancer via son centre hospitalier de pointe en cancérologie, son centre européen de recherche en cancérologie et son centre de formation. Aider à lutter contre le

cancer.

DO A POSTDOCTORAL FELLOWSHIP Each year, dozens of postdocs join Institut Curie laboratories to learn, share ideas, and actively contribute to the scientific and

medical projects.

GO30103 (TIGIT)

This first-in-human open-label, multicenter, dose-escalation study is designed to evaluate the safety, tolerability, and PK of MTIG7192A alone or in combination with atezolizumab in participants with locally advanced, recurrent, or metastatic incurable tumors for whom standard therapy does not exist, has proven to be ineffective or intolerable, or is considered inappropriate, or for whom a

NICOLAS GIRARD

Nicolas Girard is a pneumologist specializing in thoracic oncology, for the treatment of patients with lung cancer or rare thoracic cancers. He is experienced in the treatment of thymic tumors—thymomas and thymic carcinomas—as part of his work in the

RYTHMIC network.

SPATIO-TEMPORAL DYNAMICS OF IMMUNE CELLS We work at the interface of cell biology, immunology and biophysics. We aim at deciphering the fundamental cell biological mechanisms that control the spatio-temporal regulation of antigen presentation. In this context, we develop two main axis of research: the coordination between cell migration and antigen uptake and presentation in dendritic cells the role of cell This site uses cookies to provide personalized content and advertising, to make it easier to share information on social media, and to measure audience size.

Find out more

Accept Refuse Skip to main content Skip to menu Skip to footer

* Who we are

* Make an appointment

* Contact Us

* Who we are

Who we are

* Our history

* " class="is-active">Our missions * Our economic model

* Our missions

* Our organization

* Annual report

* Support us

Support us

* Where do your donations go?

* Get involved

* Our supporters

* Strategic priorities Strategic priorities

* Breast cancer

* Early trials

* Genetics and epigenetics

* Immunotherapy

* Pediatric cancer

* Radiotherapy and radiation biology

* Sarcomas

* Uveal melanoma

* Understand cancer

Understand cancer

* Breast cancer

* Childhood cancers

* Immunotherapy

* Retinoblastoma

* Sarcomas

* Uveal melanoma

* Proton therapy

* Developing the Radiotherapy of the Future

* Lung cancer

* Annual report

* Research News

* " class="fr">">FR

* " class="en is-active">">EN

* Who we are

* Make an appointment

* Contact Us

Search

Filter by

Directory of Doctors

* " class="fr">">FR

* " class="en is-active">">EN

Make a donation

* Who we are

Who we are

* Our history

* " class="is-active">Our missions * Our economic model

* Our missions

* Our organization

* Annual report

* Support us

Support us

* Where do your donations go?

* Get involved

* Our supporters

* Strategic priorities Strategic priorities

* Breast cancer

* Early trials

* Genetics and epigenetics

* Immunotherapy

* Pediatric cancer

* Radiotherapy and radiation biology

* Sarcomas

* Uveal melanoma

* Understand cancer

Understand cancer

* Breast cancer

* Childhood cancers

* Immunotherapy

* Retinoblastoma

* Sarcomas

* Uveal melanoma

* Proton therapy

* Developing the Radiotherapy of the Future

* Lung cancer

* Annual report

* Research News

Patients and relatives Institut Curie is an international expert for several types of cancers, including eye cancers, pediatric tumors, breast cancers and sarcomas. Patients from all over the world are treated at Institut

Curie.

* Our hospitals

* Adult care

* What is a clinical trial?

* Care News

* International patients

Access this area

Donors

Doctors, researchers, healthcare professionals, patients, donors: we all work together so that tomorrow, there is a life after cancer for

everyone.

* Who we are

* Support us

* Strategic priorities

* Understand cancer

* Annual report

* Research News

Access this area

Researchers

Institut Curie's internationally-renowned Research Centre studies also the aspects of cancer biology.

* Research Fields

* Collaborations

* Our research teams * Research without borders * Translational research

* Platforms

* Research News

* Research programs

Access this area

Students

Just like treatment and research, training and education are an integral part of Institut Curie’s founding social missions. Our aim is to prepare future leaders. This is essential if we are to contribute to the evolution of research and medicine and maintain our

level of excellence

* Collaborations

* Courses

* The hospital

* The Research Center

* Training News

* ADIC

Access this area

Caregivers

* " class="is-active">Refer a patient

* Contact Us

* Our expertise

* Our hospitals

* Understanding cancer

* Care News

Access this area

*

Journalists

*

TechTransfer

News

Breast cancers

Christophe Hargoues / Institut Curie COVID-19 and breast cancer 05/05/2020

Partnership

Institut Curie's Carnot label renewed for 4 years 03/25/2020

The Institut Curie

The Institut Curie was born thanks to the strong will of a woman, Marie Curie, and of her desire to fight against cancer. Our three missions aim to win this fight. CURE : a state-of-the art hospita, with the best experts and most-advanced technologies. SEARCH : an internationally-renowned research centre TEACH : teaching programmes to train tomorrow's cancer experts Make a donation Make a donation Do you want to receive Institut Curie's newsletters? I subscribe

ou

* twitter

* youtube

* facebook

* linkedin

* instagram

* Donators

* Who we are

* Strategic priorities

* Support us

* Where does your donation go? * Understanding cancer

* News

* International patients

* Who we are

* Understanding cancer * Make an appointment

* Our hospitals

* Our expertise

* Adult care

* Care News

* Researchers

* Who we are

* Understanding cancer

* Research Fields

* Our research teams * Translational research

* Research News

* Students

* Who we are

* Understanding cancer

* Contact Us

* Courses

* Collaborations

* Our hospitals

* Our research center

* Training news

* Caregivers

* Who we are

* Contact Us

* Courses and training * " class="is-active">Refer a patient * Understanding cancer

* Our expertise

* Care News

* Our hospitals

* Journalists

* All the news

* Who we are

* Copyright © 2020

* " class="is-active">Contact and Access

* Contact Us

* Directory

* Join us

* Legal Notice

* Personal data protection charter